Integer Holdings Debt to Equity Ratio 2010-2022 | ITGR
Current and historical debt to equity ratio values for Integer Holdings (ITGR) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Integer Holdings debt/equity for the three months ending September 30, 2022 was 0.68.
| Integer Holdings Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2022-09-30 |
$1.38B |
$1.36B |
1.02 |
| 2022-06-30 |
$1.40B |
$1.36B |
1.02 |
| 2022-03-31 |
$1.24B |
$1.36B |
0.91 |
| 2021-12-31 |
$1.23B |
$1.36B |
0.91 |
| 2021-09-30 |
$1.02B |
$1.33B |
0.76 |
| 2021-06-30 |
$1.05B |
$1.32B |
0.80 |
| 2021-03-31 |
$1.07B |
$1.28B |
0.83 |
| 2020-12-31 |
$1.10B |
$1.27B |
0.87 |
| 2020-09-30 |
$1.22B |
$1.23B |
0.99 |
| 2020-06-30 |
$1.34B |
$1.18B |
1.14 |
| 2020-03-31 |
$1.23B |
$1.16B |
1.06 |
| 2019-12-31 |
$1.20B |
$1.15B |
1.04 |
| 2019-09-30 |
$1.23B |
$1.13B |
1.09 |
| 2019-06-30 |
$1.26B |
$1.11B |
1.14 |
| 2019-03-31 |
$1.29B |
$1.08B |
1.20 |
| 2018-12-31 |
$1.27B |
$1.06B |
1.19 |
| 2018-09-30 |
$1.32B |
$1.04B |
1.27 |
| 2018-06-30 |
$1.89B |
$0.92B |
2.06 |
| 2018-03-31 |
$1.93B |
$0.92B |
2.09 |
| 2017-12-31 |
$1.96B |
$0.89B |
2.19 |
| 2017-09-30 |
$2.03B |
$0.82B |
2.47 |
| 2017-06-30 |
$2.06B |
$0.78B |
2.63 |
| 2017-03-31 |
$2.10B |
$0.74B |
2.83 |
| 2016-12-31 |
$2.11B |
$0.73B |
2.91 |
| 2016-09-30 |
$2.14B |
$0.74B |
2.89 |
| 2016-06-30 |
$2.18B |
$0.72B |
3.01 |
| 2016-03-31 |
$2.18B |
$0.73B |
2.98 |
| 2015-12-31 |
$2.13B |
$0.85B |
2.51 |
| 2015-09-30 |
$0.34B |
$0.65B |
0.52 |
| 2015-06-30 |
$0.33B |
$0.64B |
0.51 |
| 2015-03-31 |
$0.32B |
$0.63B |
0.51 |
| 2014-12-31 |
$0.34B |
$0.61B |
0.56 |
| 2014-09-30 |
$0.33B |
$0.60B |
0.56 |
| 2014-06-30 |
$0.33B |
$0.58B |
0.56 |
| 2014-03-31 |
$0.32B |
$0.57B |
0.57 |
| 2013-12-31 |
$0.35B |
$0.54B |
0.64 |
| 2013-09-30 |
$0.36B |
$0.52B |
0.69 |
| 2013-06-30 |
$0.39B |
$0.50B |
0.78 |
| 2013-03-31 |
$0.40B |
$0.49B |
0.81 |
| 2012-12-31 |
$0.41B |
$0.48B |
0.85 |
| 2012-09-30 |
$0.41B |
$0.48B |
0.86 |
| 2012-06-30 |
$0.40B |
$0.48B |
0.83 |
| 2012-03-31 |
$0.40B |
$0.48B |
0.84 |
| 2011-12-31 |
$0.41B |
$0.47B |
0.89 |
| 2011-09-30 |
$0.35B |
$0.46B |
0.75 |
| 2011-06-30 |
$0.36B |
$0.46B |
0.77 |
| 2011-03-31 |
$0.37B |
$0.44B |
0.83 |
| 2010-12-31 |
$0.35B |
$0.43B |
0.82 |
| 2010-09-30 |
$0.41B |
$0.41B |
1.00 |
| 2010-06-30 |
$0.43B |
$0.39B |
1.10 |
| 2010-03-31 |
$0.45B |
$0.38B |
1.18 |
| 2009-12-31 |
$0.45B |
$0.38B |
1.19 |
| 2009-09-30 |
$0.47B |
$0.38B |
1.23 |
| 2009-06-30 |
$0.44B |
$0.40B |
1.12 |
| 2009-03-31 |
$0.46B |
$0.38B |
1.20 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$2.380B |
$1.221B |
|
Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation.
|
